Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECT
NCT06765356Phase 4Active, not recruiting
- Start
- Apr 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in Atrial fibrillation (AFib) and atrial flutter (AFL). Primary endpoint: Number of Acute Procedural Success at 60 minutes. Started Apr 2025; status: active, not recruiting.
02
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT06765356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765356.